...
首页> 外文期刊>Annals of microbiology >Hypocholesterolaemic action of Lactobacillus plantarum VJC38 in rats fed a cholesterol-enriched diet
【24h】

Hypocholesterolaemic action of Lactobacillus plantarum VJC38 in rats fed a cholesterol-enriched diet

机译:植物乳杆菌 VJC38在富含胆固醇饮食的大鼠中的降胆固醇作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

This study was conducted to evaluate hypocholesterolaemic activity of probiotic strains Lactobacillus plantarum VJC38 and VJI21 in Wistar albino rats fed a cholesterol-enriched diet. The experimental animals were divided into five groups ( n ?=?6) viz., normal diet control group (NDC), hypercholesterolaemic diet (HD) control group (HDC), HD supplemented with 3?×?10_(8)?CFU/ml of L. plantarum VJC38 group (HD-C38), HD supplemented with 3?×?10_(8)?CFU/ml of L. plantarum VJI21 group (HD-I21), and HD supplemented with 3?×?10_(8)?CFU/ml of L. rhamnosus GG group (HD-GG) as positive control. Animals were administered bacterial culture by oral gavage once daily for 45?days. After trial, animals were sacrificed and blood samples were collected. Serum total cholesterol (T-CHO), triglyceride (TG), high-density lipoprotein (HDL) cholesterol, glucose, glutamyl pyruvate transaminase (GPT), and glutamyl oxaloacetate transaminase (GOT) levels were determined. Serum low-density lipoprotein (LDL) cholesterol levels were estimated using the Friedewald’s equation. Liver and fecal lipid contents and fecal cholic acids were measured. Serum T-CHO levels were significantly decreased by 15.6 and 17.4% in the HD-GG and HD-C38 groups, respectively, but not in the HD-I21 group compared with HDC group ( P ?
机译:进行这项研究以评估益生菌植物乳杆菌VJC38和VJI21在饲喂高胆固醇饮食的Wistar白化病大鼠中的降胆固醇活性。将实验动物分为五组(n≥6),即正常饮食对照组(NDC),高胆固醇血症饮食(HD)对照组(HDC),HD补充有3××10_(8)→CFU。每毫升植物乳杆菌VJC38组(HD-C38),HD补充3?×?10_(8)?CFU /毫升植物乳杆菌VJI21组(HD-I21),HD补充3?×?10_ (8)鼠李糖乳杆菌GG组(HD-GG)的CFU / ml为阳性对照。每天一次通过口管饲法对动物进行细菌培养,持续45天。试验后,处死动物并收集血样。确定了血清总胆固醇(T-CHO),甘油三酸酯(TG),高密度脂蛋白(HDL)胆固醇,葡萄糖,谷氨酰丙酮酸转氨酶(GPT)和谷氨酰草酰乙酸转氨酶(GOT)的水平。使用Friedewald方程估算血清低密度脂蛋白(LDL)胆固醇水平。测量肝和粪便脂质含量和粪便胆酸。 HD-GG和HD-C38组的血清T-CHO水平分别显着降低了15.6%和17.4%,而HD-I21组与HDC组相比则没有显着降低(P <0.05)。与HDC组相比,HD-GG和HD-C38组的血清LDL胆固醇分别降低了26.3%和27.2%(P <0.05)。 HD-I21组的血清LDL胆固醇水平与HDC组无显着差异。与HDC组相比,HD-GG和HD-C38的血清TG水平分别降低了14.2和22.8%(P <0.05)。与HDC组相比,HD-GG,HD-C38和HD-I21中的肝脏T-CHO和TG水平显着降低(P <0.05)。与HDC组相比,HD-GG,HD-C38和HD-21的致动脉粥样硬化系数值显着降低(P≤0.05)。与HDC组相比,HD-GG,HD-C38和HD-I21中的血清GPT水平分别降低了20.6、10.9和20.6%。两组之间的血清GOT水平无显着差异。与HDC组相比,HD-GG,HD-C38和HD-I21的血清葡萄糖水平显着降低(P <0.05)。 HD-C38和HD-GG组的粪便胆固醇和胆酸水平显着高于其他组(P <0.05)。这项研究表明,植物乳杆菌VJC38通过小肠中共轭胆汁酸的水解和粪便中胆固醇的排泄表现出降胆固醇的作用。在安慰剂对照的人类临床试验中验证了降胆固醇活性后,植物乳杆菌VJC38可用作降低胆固醇的益生菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号